K(ATP) Channels Trigger Migraines: Ivabradine Shows No Effect

Apr 4
1 min read

Research Summary

A study published in Cephalalgia explores the role of hyperpolarisation-activated cyclic nucleotide-gated (HCN) channels in migraines triggered by vascular ATP-sensitive potassium (K<sub>ATP</sub>) channels. Conducted with 31 participants, the double-blind, placebo-controlled trial tested ivabradine's effect on migraines induced by levcromakalim. Results showed ivabradine did not alter the incidence of migraines or headache intensity compared to placebo, with 22 of 27 participants experiencing migraines in both groups. Haemodynamic responses remained unchanged. In parallel mouse experiments, ivabradine failed to prevent or reverse hypersensitivity. These findings suggest HCN channels do not play a crucial role in migraine pain initiated by K<sub>ATP</sub> channel activation.

Study Details

📄 Title: Migraine induced by vascular K(ATP) channel activation is independent of HCN channel activity: A randomised controlled trial with translational validation.

👥 Research Team: Zhuang ZA et al.

📚 Published In: Cephalalgia

📅 Publication Date: 2026 Apr

⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.